| Date | Form | Description | Docs | XBRL | Pages |
| 05/26/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/20/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 02/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 08/18/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
| 05/22/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
44 |
| 03/09/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 09/15/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
66 |
| 06/16/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
63 |
Latest News & Events
Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology
Read More...Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call to Provide Update on Programs
Read More...